Product Information
FEBUXOSTAT 80 MG TABLET is a generic product labeled by Tris Pharma Inc, priced at $0.3297 per EA under NDC 27808020701. Its NADAC has been published 288 times since Dec 23, 2020.
Strength
80 mg/1
Manufacturer
Tris Pharma IncNDC
27808020701
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
FEBUXOSTATApproval Type
Generic (ANDA)
FDA Application
ANDA210292On Market Since
9/28/2020
Pharmacological Classes
Price Statistics
The NADAC for FEBUXOSTAT 80 MG TABLET has been published 288 times since Dec 23, 2020, and over the history we have for it it has declined 82.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3297 per EA |
|---|---|
| All-time high | $1.8756 (Mar 10, 2021) |
| All-time low | $0.2636 (Feb 18, 2026) |
| 52-week high | $0.4893 |
| 52-week low | $0.2636 |
| Median price | $0.6283 |
| Average price | $0.7192 |
| Largest weekly change | +46.7% (Feb 22, 2023) |
| Weeks tracked | 288 |
| Tracking since | Dec 23, 2020 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of FEBUXOSTAT 80 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FEBUXOSTAT 80 MG TABLET, manufactured by Tris Pharma Inc, is $0.3297 per EA (NDC 27808020701), effective Jun 24, 2026.
How has the price of FEBUXOSTAT 80 MG TABLET changed over time?
Over the history we have for it, the NADAC for FEBUXOSTAT 80 MG TABLET has declined 82.4%. It has been tracked across 288 weekly CMS publications since Dec 23, 2020.
What are the highest and lowest recorded NADAC prices for FEBUXOSTAT 80 MG TABLET?
Since Dec 23, 2020, the NADAC for FEBUXOSTAT 80 MG TABLET has ranged from a low of $0.2636 (Feb 18, 2026) to a high of $1.8756 (Mar 10, 2021), with a median of $0.6283 per EA.
Are there cheaper alternatives to FEBUXOSTAT 80 MG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as FEBUXOSTAT 80 MG TABLET, but none are currently priced below it.
Who manufactures FEBUXOSTAT 80 MG TABLET?
FEBUXOSTAT 80 MG TABLET (NDC 27808020701) is labeled by Tris Pharma Inc, and CMS classifies it as a generic product.
Related Drugs
Same classification